Zhang, Xiao-shuai http://orcid.org/0000-0001-5405-0802
Gale, Robert Peter http://orcid.org/0000-0002-9156-1676
Li, Zi-yu
Zhang, Meng-yu
Huang, Xiao-jun http://orcid.org/0000-0002-2145-6643
Jiang, Qian http://orcid.org/0000-0001-7131-0522
Funding for this research was provided by:
CAMS Innovation Fund for Medical Sciences (CIFMS)
National Nature Science Foundation of China
Article History
Received: 26 April 2022
Revised: 17 May 2022
Accepted: 25 May 2022
First Online: 1 June 2022
Competing interests
: RPG is a consultant to NexImmune Inc. and Ananexa Pharma Ascentage Pharm Group, Antengene Biotech LLC, Medical Director, FFF Enterprises Inc.; partner, AZAC Inc.; Board of Directors, Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd.
: The study was approved by the Ethics Committee of People’s Hospital Beijing compliant with principles of the Helsinki Declaration.